BioWorld MedTech, a news publication for the high-tech medical technology industry and its leaders, published an article on March 19th of this year discussing the expansion into the U.S. marketspace by Sensory Technologies Inc. (Sensory Technologies). As stated, in addition to its current presence in the North American, British and French health care markets, Sensory Technologies expects to use its most recent capital raise to move into at-risk models of care in the U.S. with eShift.
Sensory Technologies is pleased to continue to work with health care systems in the support of critical transformative work through improved patient care and experience while maintaining strong fiscal responsibility. To that end, Deloitte Corporate Finance Inc. has been retained in relation to the Series A process. With ever increasing pressures from all levels of government, both here and abroad, to improve the patient journey, Sensory Technologies is delighted to continue its work in creating positive outcomes for health care systems and patients alike.
About Sensory Technologies
Sensory Technologies is a privately held Canadian medical software company with offices in Canada, the United States and Europe. We provide an innovative solution to prevent and replace medical treatment within private and public healthcare facilities. For more information, visit www.eshiftcare.com.